SB
EVLO

Samsara BioCapital’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Samsara BioCapital’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,376
Closed -$1.39M – 21
2019
Q3 		$1.39M Hold
11,376
– – 0.94% 15
2019
Q2 		$2.04M Hold
11,376
– – 1.35% 14
2019
Q1 		$1.82M Hold
11,376
– – 1.43% 13
2018
Q4 		$2.96M Buy
+11,376
New +$2.29M 2.84% 9

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Samsara BioCapital's EVLO Position: Q4 2019 in Review

Samsara BioCapital sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2019, closing a stake of 11,376 shares — an estimated $1.39M sold.

Samsara BioCapital first reported a position in EVLO in Q4 2018 and held it in 4 quarters. The position peaked at $2.96M in Q4 2018. 42 funds tracked by Wall St. Rank hold EVLO as of Q4 2019.

  • Samsara BioCapital reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Samsara BioCapital sold 11,376 Evelo Biosciences, Inc. Common Stock shares in Q4 2019, an estimated $1.39M.
  • Samsara BioCapital first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Samsara BioCapital's Evelo Biosciences, Inc. Common Stock position peaked at $2.96M in Q4 2018.
  • 42 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2019.

Based on Samsara BioCapital's 13F filing for Q4 2019, filed 18 Feb 2020.